Health & Safety

July 9, 2012

Neurotrauma, Psychological Health office partners with VA to study PTSD treatments

by Carey Phillips
Fort Detrick, Md.

Post-traumatic stress disorder is a common anxiety disorder that can stem from any traumatic event experienced by an individual.

While there are medications currently approved by the U.S. Food and Drug Administration to treat it, they are not sufficiently effective in treating combat-related post-traumatic stress commonly seen in service members and veterans.

The U.S. Army Medical Materiel Development Activity’s Neurotrauma and Psychological Health Project Management Office signed an interagency agreement with the Veterans Affairs Cooperative Studies Program, or VACSP, to jointly conduct and support clinical studies of pharmacotherapeutics for the treatment of combat-related Post-traumatic stress disorder, knowns as PTSD, in service members and veterans.

“The interagency agreement between USAMMDA and VACSP structures how the agencies will collaborate,” said Maj. Gary Wynn, research psychiatrist with the Neurotrauma and Psychological Health Project Management Office. “While the DOD may be funding the research effort, the VA is an equal partner in the project.”

“The VA is the primary location for Veterans to receive care so we need to be looking at their populations as well as those still on active duty,” he explained.

USAMMDA and VACSP will be working together to identify and develop alternate indications for existing FDA-approved drugs used to treat other disorders.

“While these drugs are FDA-approved, they are not approved for the treatment of PTSD,” said Wynn. “In fact, many of the drugs currently being used have little, or no research supporting their off-label use in treating PTSD.”

Currently, there are two drugs that are FDA-approved for treating PTSD. However, studies have shown that these drugs are less than 50 percent effective when it comes to treating combat-related PTSD. Additionally, the side effects from these drugs can be harmful to service members and veterans.

Although these drugs have helped victims of PTSD, worldwide they have shown limited benefit for service members and veterans struggling with the aftermath of combat.

“These studies are vital to understand if and how [the drugs in the collaborative USAMMDA and VACSP study] should be used in service members and veterans,” said Wynn.

According to Wynn, the collaboration between USAMMDA and the VA will ensure the highest quality of research.




All of this week's top headlines to your email every Friday.


 
 

 

Headlines July 23, 2014

News: Israel’s Iron Dome defense in line for tripled U.S. spending - Israel’s iron Dome missile defense system may end up getting triple the U.S. funding that the Defense Department sought for it in March. Ukraine asked U.S. for systems to counter Russian missiles - A month before the United States says a Russian missile likely brought...
 
 

News Briefs July 23, 2014

U.S. military deaths in Afghanistan at 2,194 As of July 22, 2014, at least 2,194 members of the U.S. military had died in Afghanistan as a result of the U.S.-led invasion of Afghanistan in late 2001, according to an Associated Press count. The AP count is three less than the Defense Department’s tally. At least...
 
 
Raytheon photograph

Raytheon completes key Air, Missile Defense Radar reviews

Raytheon photograph Partially-populated, full-sized Air and Missile Defense Radar array. Raytheon has completed two critical program reviews for the new Air and Missile Defense Radar, the U.S. Navy’s next generation integ...
 

 
Insitu photograph

Insitu demonstrates long endurance capabilities of Integrator unmanned aircraft

Insitu photograph Insitu’s Integrator unmanned aircraft recovers via SkyHook; the aircraft recently completed a 24-hour endurance flight. Insitu announced July 22 the successful 24-hour flight of its Integrator unmanned a...
 
 

NASA partners punctuate summer with spacecraft development advances

Spacecraft and rocket development is on pace this summer for NASA’s aerospace industry partners for the agency’s Commercial Crew Program as they progress through systems testing, review boards and quarterly sessions under their† Space Act Agreements with the agency. NASA engineers and specialists continue their review of the progress as the agency and partners move...
 
 

U.S. Navy selects Northrop Grumman for ship self-defense system

The U.S. Navy has awarded Northrop Grumman a $12 million task order for a full range of engineering services to continue modernizing the Ship Self-Defense System Mark 2. The contract has a potential value of $61 million over five years, if all options are exercised. SSDS MK2 is a combat system designed for anti-air defense...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>